Sunmax Biotechnology , Ltd. Profit Margin

As of the most recent data (June 2026), 4728.TWO shows a profit margin of 36.97%. That compares with 35.82% in the prior-year period — up 3.2% year over year. That is above the Healthcare sector average of 9.71%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4728.TWO's profit margin is now 36.97% (was 35.82%) — a 3.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sunmax Biotechnology , Ltd. is outperforming or lagging.

The Healthcare sector average profit margin is about 9.71%. Sunmax Biotechnology , Ltd. is at 36.97%, which is higher that average. That is roughly 280.9% above the sector mean. Use the comparison chart on this page to see how 4728.TWO stacks up against individual peers as well.

That compares with 35.82% in the prior-year period — up 3.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sunmax Biotechnology , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Sunmax Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 36.97%) with ownership activity and broader fundamentals.